Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeutics

af Brinson, Robert G., Marino, John P., Delaglio, Frank, Arbogast, Luke W., Evans, Ryan M., Kearsley, Anthony, Gingras, Geneviève, Ghasriani, Houman, Aubin, Yves, Pierens, Gregory K., Jia, Xinying, Mobli, Mehdi, Grant, Hamish G., Keizer, David W., Schweimer, Kristian, Ståhle, Jonas, Widmalm, Göran, Zartler, Edward R., Lawrence, Chad W., Reardon, Patrick N., Cort, John R., Xu, Ping, Ni, Feng, Yanaka, Saeko, Kato, Koichi, Parnham, Stuart R., Tsao, Desiree, Blomgren, Andreas, Rundlöf, Torgny, Trieloff, Nils, Schmieder, Peter, Ross, Alfred, Skidmore, Ken, Chen, Kang, Keire, David, Freedberg, Darón I., Suter-Stahel, Thea, Wider, Gerhard, Ilc, Gregor, Plavec, Janez, Bradley, Scott A., Baldisseri, Donna M., Sforça, Mauricio Luis, Zeri, Ana Carolina de Mattos, Wei, Julie Yu, Szabo, Christina M., Amezcua, Carlos A., Jordan, John B., Wikström, Mats
Udgivet i MAbs (2018)